Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics
NCT00692341
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Insufficiency
Interventions
DRUG:
AG-013736
DRUG:
AG-013736
DRUG:
AG-013736
Sponsor
Pfizer